Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FXL92
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $64,995
Award facts
- Contract value 100% obligated
- $64,994.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $65,000 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets (30-count units), with a completion date of September 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order falls under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in fulfilling diverse medical supply needs across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen alongside other qualified contractors in this strategic healthcare procurement initiative.
Quick answers
Who was awarded contract SPE2DB25FXL92?
SPE2DB25FXL92 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FXL92 worth?
The government has obligated $64,995 on SPE2DB25FXL92.
Is contract SPE2DB25FXL92 an order under another contract?
Yes. SPE2DB25FXL92 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXL92 competed?
The extent of competition for SPE2DB25FXL92 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award